SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla ($TSLA) is trending as it reached new all-time highs, fueled by optimism surrounding robotaxi testing in Austin and expansion plans in Europe. Community discussions revolve around the company's valuation and the potential for further gains, while some express skepticism and highlight competition in the autonomous vehicle space.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is trending amid discussions about OpenAI potentially raising billions from the company and utilizing its AI chips, sparking debate around the benefits to AMZN versus chip manufacturers. The community is weighing the significance of this investment for Amazon's infrastructure and AWS, while also considering broader market dynamics and whether the stock is currently undervalued. Some traders express frustration with the stock's performance, citing concerns about leadership and selling pressure.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending amid speculation surrounding potential rescheduling of cannabis, driven by reports of an upcoming executive order from President Trump, which has fueled significant trading volume. The community is closely watching for official confirmation, with many anticipating substantial gains if the rescheduling occurs, while some caution against potential pullbacks or dilution. Discussions range from short-term trading strategies to long-term investment perspectives, reflecting high interest in the cannabis sector's potential.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is trending as silver prices surge to new highs, driven by speculation around supply constraints and increased industrial demand, particularly for AI data centers. The community is discussing potential for further gains, with some pointing to historical patterns and a possible shift in market dynamics as financial institutions adjust their positions. Concerns about market manipulation and the impact of COMEX margin hikes are also circulating among investors.

nLIGHT, Inc. engages in the provision of semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. It operates through the Laser Products and Advanced Development segments. The Laser Products segment designs, manufactures, and sells a range of semiconductor lasers and fiber lasers that are typically integrated into laser systems or manufacturing tools built by customers. The Advanced Development segment focuses on research, design, and prototyping of next-generation laser technologies, leveraging expertise in laser technology, development, beam control, and advanced optics. The company was founded by Scott H. Keeney, Mark DeVito, and Jason Farmer in June 2000 and is headquartered in Camas, WA.

nLIGHT Inc

nLIGHT ($LASR) is trending as traders discuss its potential breakout, noting that it is coiling under resistance. Community members are watching for volume expansion to confirm a fresh trend in this mid-cap laser tech company. Some also point to possible defense contracts, such as the "Golden Dome", as a catalyst.

Affirm Holdings, Inc. operates a platform for digital and mobile-first commerce. Its platform consists of three core elements: a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The company was founded by Max R. Levchin in 2012 and is headquartered in San Francisco, CA.

Affirm Holdings Inc - Ordinary Shares - Class A

Affirm Holdings Inc

Affirm ($AFRM) is trending as investors discuss its extended partnership with Amazon, highlighting the potential win-win scenario for both companies. Community members are expressing optimism about Affirm's growth prospects and potential to disrupt the credit card industry, while also weighing valuation concerns and the broader competitive landscape in the BNPL sector. Some analysts have reiterated positive ratings and price targets, contributing to the increased attention.

BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Francis Patrick McCormick, Philip Reilly, and Neil Kumar in 2015 and is headquartered in Palo Alto, CA.

BridgeBio Pharma Inc

BBIO is trending due to positive analyst upgrades and strong market performance, with discussions focusing on the potential of Attruby and upcoming pipeline catalysts. Community chatter includes speculation about a potential buyout, with some expressing concerns about insider selling while others remain bullish due to upcoming Phase 3 trial results and revenue potential. The stock's technical setup and analyst ratings continue to fuel investor interest.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

MSOS is trending amid rising speculation that the US government may soon reclassify cannabis, potentially as early as this week, spurring optimism for US-based cannabis companies. Community members are actively discussing the potential impact of rescheduling on tax benefits and institutional investment, anticipating a significant boost for the sector. Some traders are closely watching for a potential address to the nation, suggesting it could entail this highly anticipated news.

RYTHM, Inc. engages in the development of hardware and software solutions for indoor agriculture. The company was founded on June 6, 2016 and is headquartered in Rolling Meadows, IL.

RYTHM Inc.

RYM is trending due to anticipation surrounding potential rescheduling of cannabis to Schedule 3 and a recent interview mentioning a possible signing date, sparking excitement among investors. Community members are discussing the company's growth potential, sizable cash position, and potential royalties from Green Thumb Industries. Bullish sentiment is also fueled by the growth of its THC beverage brand, Seorita, and speculation about Green Thumb uplisting.

PBF Energy, Inc. engages in the operation of a petroleum refinery and supplies unbranded transportation fuels, heating oil, petrochemical feed stocks, lubricants, and other petroleum products in the United States. It operates through the Refining and Logistics segments. The Refining segment is involved in refining crude oil and other feed stocks into petroleum products. The Logistics segment includes owning, leasing, operation, development, and acquisition of crude oil and refined petroleum products terminals, pipelines, storage facilities, and logistics assets. The company was founded on March 1, 2008 and is headquartered in Parsippany, NJ.

PBF Energy Inc - Ordinary Shares - Class A

PBF Energy ($PBF) is trending due to its oversold condition, indicated by a low RSI, leading to speculation of a potential bullish reversal. Community discussions revolve around actionable trade alerts, with possible entry points and profit targets being debated. Some analysts are adjusting their ratings, and while the stock is trading below moving averages, the oversold RSI provides a counterpoint for a possible price bounce.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Receives Average Recommendation of "Moderate Buy" from Brokerages

Shares of Atara Biotherapeutics, Inc. (NASDAQ:ATRA - Get Free Report) have been assigned an average rating of "Moderate Buy" from the six brokerages that are covering the company, MarketBeat Ratings...

Atara Biotherapeutics (NASDAQ:ATRA) CAO Sells $23,794.76 in Stock

Atara Biotherapeutics, Inc. (NASDAQ:ATRA - Get Free Report) CAO Yanina Grant-Huerta sold 1,804 shares of the firm's stock in a transaction on Monday, November 17th. The stock was sold at an average...

Atara Biotherapeutics (NASDAQ:ATRA) CEO Anhco Nguyen Sells 2,915 Shares

Atara Biotherapeutics, Inc. (NASDAQ:ATRA - Get Free Report) CEO Anhco Nguyen sold 2,915 shares of the company's stock in a transaction that occurred on Monday, November 17th. The shares were sold at...

Atara Biotherapeutics (NASDAQ:ATRA) Issues Quarterly Earnings Results, Beats Estimates By $0.51 EPS

Atara Biotherapeutics (NASDAQ:ATRA - Get Free Report) announced its quarterly earnings results on Wednesday. The biotechnology company reported ($0.32) EPS for the quarter, topping analysts...

Atara Biotherapeutics Announces Third Quarter Financial Results and Operational Progress

Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients...

Wave Life Sciences (WVE) Reports Q3 Loss, Misses Revenue Estimates

Wave Life Sciences (WVE) delivered earnings and revenue surprises of -6.67% and -41.25%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Atara Biotherapeutics (ATRA) Surges 10.0%: Is This an Indication of Further Gains?

Atara Biotherapeutics (ATRA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Pacira (PCRX) Tops Q3 Earnings Estimates

Pacira (PCRX) delivered earnings and revenue surprises of +7.69% and -1.60%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Adma Biologics (ADMA) Q3 Earnings Match Estimates

Adma Biologics (ADMA) delivered earnings and revenue surprises of 0.00% and +3.17%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Atara Biotherapeutics (ATRA) Soars 10.0%: Is Further Upside Left in the Stock?

Atara Biotherapeutics (ATRA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in Thousand Oaks, CA.

Atara Biotherapeutics Inc

Up more than 2%

Up 0–2%

Flat to down 2%

Down more than 2%

The S&P 500 is modestly lower so far in December, putting the Santa Claus rally in question. The Santa Claus rally refers to the market’s tendency to rise in the final weeks of the year—what do you expect from December 16 through December 31?

What do you expect the S&amp;P 500’s total return to be in the second half of December?

Stocktwits

What do you expect the S&P 500’s total return to be in the second half of December?

ATRA
Atara Biotherapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ATRA News

ATRAAtara Biotherapeutics Inc